Dr. Reddy's Laboratories Balance Sheet - Annual (NYSE:RDY)

Add to My Stocks
$34.07 $0.18 (0.53%) RDY stock closing price Jun 22, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Dr. Reddy's Laboratories balance sheet. As in our Dr. Reddy's Laboratories stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. The Dr. Reddy's Laboratories balance sheet for 2018 shows total assets of $3.49B. The company has a asset turnover ratio of 0.63. Also see: Dr. Reddy's Laboratories revenue and Dr. Reddy's Laboratories operating cash flow for the same year.

View latest 10 year balance sheet data to check Dr. Reddy's Laboratories financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Apr - Mar2018201720162015201420132012201120102009
Marketable Securities309.5M224M532M563M427M321M212M1M80M10M
Raw Materials-147.14M118.11M140.17M------
Work In Progress-102M106.39M108.63M------
Finished Goods-190.84M161.53M160.9M------
Notes Receivable----------
Other Current Assets197.81M238M191M210M211M174M140M183M147M99M
Total Current Assets
Property Plant & Equipment-1.54B1.36B1.25B------
Accumulated Depreciation-662.44M546.04M482.1M------
Net Property Plant & Equipment
Investment & Advances83.83M106M50M62M13M13M7M7M7M5M
Other Non-Current Assets2.61M3M--------
Deferred Charges83.77M86M75M93M101M67M39M43M29M25M
Deposits & Other Assets78.91M15M16M12M8M9M9M6M5M4M
Total Assets
Notes Payable----343M348M311M411M125M188M
Accounts Payable206.84M207M186M171M175M218M187M190M207M118M
Current Portion Long-Term Debt698.41M674M347M470M57M94M1M-82M-
Current Portion Capital Leases----------
Accrued Expenses----20M18M---12M
Income Taxes Payable23.71M23M39M40M--13M28M32M-
Other Current Liabilities139.56M407M405M346M306M306M342M292M200M204M
Total Current Liabilities
Deferred Taxes/Income30.22M19M12M29M46M36M22M45M61M92M
Convertible Debt----------
Long-Term Debt388.87M84M161M230M346M232M321M118M120M199M
Non-Current Capital Leases----------
Other Long-Term Liabilities58.12M64M49M54M32M19M22M16M5M8M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net12.86M13M13M14M14M16M17M19M19M17M
Capital Surplus-113M341M356M359M389M411M464M454M397M
Retained Earnings-1.67B1.5B1.34B1.08B822M621M458M401M360M
Treasury Stock----------
Other Liabilities1.94B117M81M74M56M114M80M92M81M53M
Shareholders Equity1.95B1.91B1.94B1.79B1.51B1.34B1.13B1.03B955M827M
Total Liabilities & Shareholders Equity3.49B3.39B3.13B3.13B2.84B2.61B2.35B2.13B1.79B1.65B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Dr. Reddy's Laboratories stock price by looking at Dr. Reddy's Laboratories historical stock prices. One can compare PE with industry average by looking at the Dr. Reddy's Laboratories PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the Dr. Reddy's Laboratories company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Dr. Reddy's Laboratories had total assets of $3.49B.
  • Liabilities: The total liabilities of Dr. Reddy's Laboratories for the year 2018 total to $1.55B. Liabilities for a company like Dr. Reddy's Laboratories include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Dr. Reddy's Laboratories Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio